• About us
  • Contact us
  • Our team
  • Terms of Service
Friday, November 13, 2026
Kashmir Images - Latest News Update
Epaper
  • TOP NEWS
  • CITY & TOWNS
  • LOCAL
  • BUSINESS
  • NATION
  • WORLD
  • SPORTS
  • OPINION
    • EDITORIAL
    • ON HERITAGE
    • CREATIVE BEATS
    • INTERALIA
    • WIDE ANGLE
    • OTHER VIEW
    • ART SPACE
  • Photo Gallery
  • CARTOON
  • EPAPER
No Result
View All Result
Kashmir Images - Latest News Update
No Result
View All Result
Home BUSINESS

Pharma sector may post 17% revenue growth in June qtr: Report

Press Trust of india by Press Trust of india
July 9, 2018
in BUSINESS
A A
0
FacebookTwitterWhatsapp

Mumbai, Jul 8 :  The pharmaceutical industry is likely to report a 17 per cent revenue growth in the June quarter, driven by strong domestic growth and currency tailwinds, said a report.

“Overall revenue for the pharma sector is likely to grow 17 per cent YoY (year-on-year) and PAT 50 per cent YoY,” Edelweiss Securities said in its report.

More News

Indian economy has been ‘shining star’ in otherwise ‘gloomy world’: NITI Aayog VC

Retail inflation breaches RBI’s upper tolerance band at 6.09%; rate hike likely next month

Earlier PM said ‘sab changa si’, now it is ‘sab mehnga si’: Cong taunts govt over price rise

Load More

“Domestic sales are likely to spike 26 per cent on the back of a low base due to GST-related disruption,” it added.

The US sales in constant currency is expected to grow 6 per cent in annual terms, but fall 2 per cent in quarterly terms, on lack of any meaningful launch during the June quarter, according to the report.

Currency tailwinds, namely the rupee’s 4 per cent depreciation against the US dollar and 11 and 5 per cent fall against the euro and yen, respectively, are likely to drive EBITDA margin expansion of 350 bps in annual terms and 100 bps in quarterly terms in the June quarter, it said.

Edelweiss Securities said that the optimism is on favourable regulatory environment.

The US Food and Drug Administration (USFDA) approval rate rebounded to 198 nods after a temporary hiatus in the March quarter, with 109 approvals due to extra documentation requirements for elemental impurities, the report revealed.

Following the recent USFDA clearance of Sun Pharma’s Halol plant, the report said piled-up filings are expected to keep the approval rate buoyant for domestic pharma companies.

“On the regulatory front, favourable inspections at Cadila’s topicals plant, Dr Reddy’s Medak, Srikakulam SEZ, UK, and Sun Pharma’s Halol plant demonstrate that the worst in terms of regulatory issues is over,” it said.

Edelweiss Securities, however, said that the pricing challenges in the US is still cause of concern.

“Though the Q1FY19 results will be seemingly better, we believe underlying growth will remain muted. However, initial signs of rebound in domestic markets is key positive,” it said.

The domestic pharmaceutical sector accounts for 3.1-3.6 per cent of the global pharmaceutical industry in value terms and 10 per cent in volume terms.

It is expected to grow to USD 100 billion by 2025, according to the report.

Previous Post

Su-raj (good governance) and Ms Swaraj

Next Post

HRD ministry sanctions 68 Girls Hostels, 99 KGBV’s for JK

Press Trust of india

Press Trust of india

Related Posts

Indian economy has been ‘shining star’ in otherwise ‘gloomy world’: NITI Aayog VC

Indian economy has been ‘shining star’ in otherwise ‘gloomy world’: NITI Aayog VC
November 12, 2026

New Delhi: The Indian economy has been the "shining star" in an otherwise "gloomy world", as the country has maintained...

Read moreDetails

Retail inflation breaches RBI’s upper tolerance band at 6.09%; rate hike likely next month

Wholesale inflation hits three-month high of 0.53% in March
November 12, 2026

New Delhi: Retail inflation surged to 6.09 per cent in October, breaching the Reserve Bank's upper tolerance limit for the...

Read moreDetails

Earlier PM said ‘sab changa si’, now it is ‘sab mehnga si’: Cong taunts govt over price rise

PM leaving no stone unturned to save ‘flailing image’: Cong slams UGC’s ‘selfie points’ directive
November 12, 2026

New Delhi: The Congress on Thursday targeted the Modi government over rising prices, and said the public wants inflation to...

Read moreDetails

World leaders urge stronger and faster action at UN climate talks over inadequate response

World leaders urge stronger and faster action at UN climate talks over inadequate response
November 11, 2026

Antalya (Turkiye):  World leaders began formal talks at the United Nations climate conference in Turkiye on Wednesday, seeking agreement on...

Read moreDetails

India’s renewable energy expansion averts $100 bn in fuel imports, savings seen at $240 bn by 2030

‘J&K leading the charge in electricity sector reforms’
November 11, 2026

New Delhi: India's rapid expansion of renewable energy has helped the country avoid more than USD 100 billion (about Rs...

Read moreDetails

Govts investing heavily in bioeconomy; India best example of demand, supply growing together: WEF

Global recession likely in 2023; India may benefit from diversification of supply chains: WEF survey
November 10, 2026

New Delhi: Governments across the world are investing heavily in bioeconomy development and India provides the clearest example of demand...

Read moreDetails
Next Post
HRD ministry sanctions 68 Girls Hostels, 99 KGBV’s for JK

HRD ministry sanctions 68 Girls Hostels, 99 KGBV’s for JK

  • About us
  • Contact us
  • Our team
  • Terms of Service
E-Mailus: kashmirimages123@gmail.com

© 2025 Kashmir Images - Designed by GITS.

No Result
View All Result
  • TOP NEWS
  • CITY & TOWNS
  • LOCAL
  • BUSINESS
  • NATION
  • WORLD
  • SPORTS
  • OPINION
    • EDITORIAL
    • ON HERITAGE
    • CREATIVE BEATS
    • INTERALIA
    • WIDE ANGLE
    • OTHER VIEW
    • ART SPACE
  • Photo Gallery
  • CARTOON
  • EPAPER

© 2025 Kashmir Images - Designed by GITS.